LPCN - Lipocine Inc
Lipocine Inc Logo

LPCN - Lipocine Inc

https://www.lipocine.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.

52W High
$6.17
52W Low
$2.68
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.28
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.65
EV/Revenue (<3 favorable)
0.62
P/S (TTM) (<3 favorable)
3.72
P/B (<3 favorable)
0.91
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
2.91%
Institutions (25–75% balanced)
9.81%
Shares Outstanding
5,419,000
Float
5,261,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
4,208,100
Gross Profit (TTM)
4,208,100
EPS (TTM)
-0.84
Profit Margin (>10% good)
-1.07%
Operating Margin (TTM) (higher better)
-3.86%
ROE (TTM) (>15% strong)
-0.24%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
5.95
Momentum
Bearish momentum
Value
-0.0467
Previous
-0.0547
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025